The consequences of cohesin mutations in myeloid malignancies

Recurrent somatic mutations in the genes encoding the chromatin-regulatory cohesin complex and its modulators occur in a wide range of human malignancies including a high frequency in myeloid neoplasms. The cohesin complex has a ring-like structure which can enclose two strands of DNA. A first funct...

Full description

Bibliographic Details
Main Authors: Shubhra Ashish Bhattacharya, Eve Dias, Andrea Nieto-Aliseda, Marcus Buschbeck
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-11-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2023.1319804/full
_version_ 1797614256391192576
author Shubhra Ashish Bhattacharya
Shubhra Ashish Bhattacharya
Eve Dias
Eve Dias
Andrea Nieto-Aliseda
Marcus Buschbeck
Marcus Buschbeck
author_facet Shubhra Ashish Bhattacharya
Shubhra Ashish Bhattacharya
Eve Dias
Eve Dias
Andrea Nieto-Aliseda
Marcus Buschbeck
Marcus Buschbeck
author_sort Shubhra Ashish Bhattacharya
collection DOAJ
description Recurrent somatic mutations in the genes encoding the chromatin-regulatory cohesin complex and its modulators occur in a wide range of human malignancies including a high frequency in myeloid neoplasms. The cohesin complex has a ring-like structure which can enclose two strands of DNA. A first function for the complex was described in sister chromatid cohesion during metaphase avoiding defects in chromosome segregation. Later studies identified additional functions of the cohesin complex functions in DNA replication, DNA damage response, 3D genome organisation, and transcriptional regulation through chromatin looping. In this review, we will focus on STAG2 which is the most frequently mutated cohesin subunit in myeloid malignancies. STAG2 loss of function mutations are not associated with chromosomal aneuploidies or genomic instability. We hypothesize that this points to changes in gene expression as disease-promoting mechanism and summarize the current state of knowledge on affected genes and pathways. Finally, we discuss potential strategies for targeting cohesion-deficient disease cells.
first_indexed 2024-03-11T07:07:04Z
format Article
id doaj.art-f3bea6c1a41c4c3a8e68ac2069895386
institution Directory Open Access Journal
issn 2296-889X
language English
last_indexed 2024-03-11T07:07:04Z
publishDate 2023-11-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Molecular Biosciences
spelling doaj.art-f3bea6c1a41c4c3a8e68ac20698953862023-11-17T08:55:54ZengFrontiers Media S.A.Frontiers in Molecular Biosciences2296-889X2023-11-011010.3389/fmolb.2023.13198041319804The consequences of cohesin mutations in myeloid malignanciesShubhra Ashish Bhattacharya0Shubhra Ashish Bhattacharya1Eve Dias2Eve Dias3Andrea Nieto-Aliseda4Marcus Buschbeck5Marcus Buschbeck6Program of Myeloid Neoplasms, Program of Applied Epigenetics, Josep Carreras Leukaemia Research Institute, Badalona, SpainPhD Program of Cell Biology, Autonomous University of Barcelona, Barcelona, SpainProgram of Myeloid Neoplasms, Program of Applied Epigenetics, Josep Carreras Leukaemia Research Institute, Badalona, SpainPhD Program of Cell Biology, Autonomous University of Barcelona, Barcelona, SpainProgram of Myeloid Neoplasms, Program of Applied Epigenetics, Josep Carreras Leukaemia Research Institute, Badalona, SpainProgram of Myeloid Neoplasms, Program of Applied Epigenetics, Josep Carreras Leukaemia Research Institute, Badalona, SpainGermans Trias i Pujol Research Institute (IGTP), Badalona, SpainRecurrent somatic mutations in the genes encoding the chromatin-regulatory cohesin complex and its modulators occur in a wide range of human malignancies including a high frequency in myeloid neoplasms. The cohesin complex has a ring-like structure which can enclose two strands of DNA. A first function for the complex was described in sister chromatid cohesion during metaphase avoiding defects in chromosome segregation. Later studies identified additional functions of the cohesin complex functions in DNA replication, DNA damage response, 3D genome organisation, and transcriptional regulation through chromatin looping. In this review, we will focus on STAG2 which is the most frequently mutated cohesin subunit in myeloid malignancies. STAG2 loss of function mutations are not associated with chromosomal aneuploidies or genomic instability. We hypothesize that this points to changes in gene expression as disease-promoting mechanism and summarize the current state of knowledge on affected genes and pathways. Finally, we discuss potential strategies for targeting cohesion-deficient disease cells.https://www.frontiersin.org/articles/10.3389/fmolb.2023.1319804/fullcohesinSTAG2chromatinmyelodysplastic syndromesacute myeloid leukemia
spellingShingle Shubhra Ashish Bhattacharya
Shubhra Ashish Bhattacharya
Eve Dias
Eve Dias
Andrea Nieto-Aliseda
Marcus Buschbeck
Marcus Buschbeck
The consequences of cohesin mutations in myeloid malignancies
Frontiers in Molecular Biosciences
cohesin
STAG2
chromatin
myelodysplastic syndromes
acute myeloid leukemia
title The consequences of cohesin mutations in myeloid malignancies
title_full The consequences of cohesin mutations in myeloid malignancies
title_fullStr The consequences of cohesin mutations in myeloid malignancies
title_full_unstemmed The consequences of cohesin mutations in myeloid malignancies
title_short The consequences of cohesin mutations in myeloid malignancies
title_sort consequences of cohesin mutations in myeloid malignancies
topic cohesin
STAG2
chromatin
myelodysplastic syndromes
acute myeloid leukemia
url https://www.frontiersin.org/articles/10.3389/fmolb.2023.1319804/full
work_keys_str_mv AT shubhraashishbhattacharya theconsequencesofcohesinmutationsinmyeloidmalignancies
AT shubhraashishbhattacharya theconsequencesofcohesinmutationsinmyeloidmalignancies
AT evedias theconsequencesofcohesinmutationsinmyeloidmalignancies
AT evedias theconsequencesofcohesinmutationsinmyeloidmalignancies
AT andreanietoaliseda theconsequencesofcohesinmutationsinmyeloidmalignancies
AT marcusbuschbeck theconsequencesofcohesinmutationsinmyeloidmalignancies
AT marcusbuschbeck theconsequencesofcohesinmutationsinmyeloidmalignancies
AT shubhraashishbhattacharya consequencesofcohesinmutationsinmyeloidmalignancies
AT shubhraashishbhattacharya consequencesofcohesinmutationsinmyeloidmalignancies
AT evedias consequencesofcohesinmutationsinmyeloidmalignancies
AT evedias consequencesofcohesinmutationsinmyeloidmalignancies
AT andreanietoaliseda consequencesofcohesinmutationsinmyeloidmalignancies
AT marcusbuschbeck consequencesofcohesinmutationsinmyeloidmalignancies
AT marcusbuschbeck consequencesofcohesinmutationsinmyeloidmalignancies